OptimizeRx OPRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$495K+77.5% | $5.02M+6,536% | $779K+109% | $1.53M+138% | -$2.2M+68.1% | ||
| $1.06M-2.7% | $1.08M-1.5% | $1.08M-1.4% | $1.07M+0.1% | $1.09M+2.5% | ||
| $1.83M+17.3% | $1.96M-33.3% | $1.96M-24.9% | $1.49M-48.7% | $1.56M-48.5% | ||
| $50K-92.9% | -$1.21M-168% | -$1.03M+36.4% | $328K+130% | $705K— | ||
| $358K+106% | $325K+12.8% | $174K-4.4% | $437K+140% | $174K-4.4% | ||
| $0— | $0-100% | $0+100% | $0— | $0-100% | ||
| -$5.76M-4.9% | —— | -$1.29M-171% | —— | -$5.49M+13.8% | ||
| $1.43M+16.7% | -$401K+33.1% | —— | -$1.4M-206% | $1.23M+318% | ||
| -$7.99M-1,035% | $1.46M-52.1% | —— | $3.28M+273% | $854K+336% | ||
| $290K+492% | $19K+101% | —— | $1.03M-54.3% | -$74K+90.8% | ||
| $166K+337% | $108K+43.5% | -$89K-218% | —— | $38K-94.8% | ||
| -$119K+72.4% | —— | -$1.1M-160% | -$533K+54.8% | -$431K-233% | ||
| -$2K— | —— | $6K— | $9K— | $0— | ||
| -$467K-112% | $7.09M+3,480% | $3.2M+78.8% | $4.56M+483% | $3.86M+82.4% | ||
| $21K-22.2% | $11K-35.3% | $10K-44.4% | $10K-77.8% | $27K-15.6% | ||
| -$21K+75.0% | $206K+272% | -$10K+89.1% | -$44K+48.2% | -$84K+45.1% | ||
| $2.69M+438% | $2.5M0.0% | $500K0.0% | $4.5M+800% | $500K0.0% | ||
| $17K-80.5% | —— | —— | $5K-98.8% | $87K-37.9% | ||
| -$2.71M-361% | -$3.45M-22.1% | -$258K+51.5% | -$4.51M-392% | -$587K+8.3% | ||
| -$3.2M-200% | $3.85M+240% | $2.93M+151% | $12K+106% | $3.19M+141% | ||
| $798K-28.8% | $916K-56.8% | $980K-28.5% | $1.17M-14.2% | $1.12M-17.0% | ||
| $12K— | $753K+368% | $0+100% | $1.09M+1,121% | $0-100% | ||
| $358K+106% | $325K+12.8% | $174K-4.4% | $437K+140% | $174K-4.4% | ||
| —— | $92K-95.1% | $92K-95.1% | $92K-95.1% | $92K-95.1% | ||
| -$7.99M-1,035% | $1.46M-52.1% | —— | $3.28M+273% | $854K+336% | ||
| -$119K+72.4% | —— | -$1.1M-160% | -$533K+54.8% | -$431K-233% | ||
| $50K-92.9% | -$1.21M+60.5% | -$1.03M-164% | $328K— | $705K— | ||
| —— | $62.5K0.0% | $62.5K0.0% | $62.5K0.0% | $62.5K0.0% | ||
| -$2K— | —— | $6K— | $9K— | $0— | ||
| $290K+492% | $19K+101% | —— | $1.03M-54.3% | -$74K+90.8% | ||
| -$2.13M+35.6% | —— | -$262K— | —— | -$3.31M-23.0% | ||
| $0— | $0-100% | $0+100% | $0— | $0-100% | ||
| $0-100% | —— | —— | $34K-15.0% | $57K-52.9% | ||
| -$488K-113% | $7.08M+3,810% | $3.19M+80.0% | $4.55M+518% | $3.84M+83.9% | ||
| -$488K-113% | $7.08M+3,810% | $3.19M+80.0% | $4.55M+518% | $3.84M+83.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OptimizeRx generate?
- OptimizeRx (OPRX) generated $14.4M in operating cash flow over the trailing twelve months.
- What is OptimizeRx's free cash flow?
- After $52.0K of capital expenditures, OptimizeRx's free cash flow was $14.3M over the trailing twelve months, up 119.5% year over year.
- Where does OptimizeRx's cash flow data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
